FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to using 1-{4-[1-(4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl]-2-ethylbenzyl}azetidine-3-carboxylic acid or its pharmacologically acceptable salt in treating demyelinated peripheral neuropathy specified in chronic inflammatory demyelinated polyradiculoneuropathy, multifocal motor neuropathy with conduction block or paraproteinemic demyelinated peripheral neuropathy.
EFFECT: using 1-{4-[1-(4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl]-2-ethylbenzyl}azetidine-3-carboxylic acid for treating demyelinated peripheral neuropathy 
.
4 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF GLYCOPEPTIDE OR THEIR SALTS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2145609C1 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
| IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677699C1 |
| NOVEL DERIVATIVES OF IMIDAZOLIDINE, THEIR PREPARING AND USING AS VLA-4 ANTAGONIST | 2002 |
|
RU2318815C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| CONDENSED BICYCLIC COMPOUNDS FOR TREATING DISEASE | 2015 |
|
RU2741387C2 |
| NEW FIVE-MEMBER HETEROCYCLES, THEIR PREPARING, THEIR APPLYING AND PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF | 1998 |
|
RU2240326C2 |
| PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
| CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
